SNGX Dana dhuwit perusahaan Soligenix, Inc.

Simbol lan logo merek soligenix.com (SNGX)

Soligenix, Inc. (SNGX) is protected by patents for counter-bioterrorism and receives support from the Pentagon. Diversification between oncology and vaccines mitigates risks, although it necessitates government subsidies. The volume of physical cash visualizes financial autonomy, where 0.01 forms the current metric indicator. Effective distribution within the biosecurity segment guarantees the stability of drug supplies to the healthcare system.

Cadangan dhuwit perusahaan: soligenix.com (SNGX) kanggo 04.07.2022 - 21.11.2026

Rincian analitis lan laporan data perusahaan Soligenix, Inc. (SNGX)

- nilai saham lan prakiraan konsensus rega:
Analisis wiwitan perusahaan:Soligenix
Produk merek BioPharma Bio

This indicator measures liquid cash reserves, determining the business's ability to cover operating expenses and withstand market volatility without incurring external debt. By analyzing the organization's cash balances through GURU.Markets tools, an investor can assess the resource base of Soligenix, Inc. (SNGX) for financing strategic alliances with defense agencies and acquiring new biopharmaceutical patents.